Z650

DRUG2 trials

Sponsors

Sunshine Lake Pharma Co., Ltd.

Conditions

Esophageal Squamous Cell CarcinomaPancreatic Cancer

Phase 1

Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification

CompletedNCT03888092

Sunshine Lake Pharma Co., Ltd.Esophageal Squamous Cell Carcinoma

Start: 2017-08-18End: 2022-12-13Updated: 2023-03-21

Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer

TerminatedNCT04131192

Sunshine Lake Pharma Co., Ltd.Pancreatic Cancer

Start: 2019-11-11End: 2021-09-09Updated: 2022-05-06

Related Papers

Larotinib in patients with advanced and previously treated esophageal squamous cell carcinoma with epidermal growth factor receptor overexpression or amplification: an open-label, multicenter phase 1b study

BMC Gastroenterology2021-10-239 citations